$GILD Company News

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 12:49 PM

$GILD Company News

Gilead Sciences shares slide 1.7%
9:35 a.m. Nov. 19, 2014
- Sue Chang

Are consumers getting gouged on health care?
12:58 p.m. Nov. 18, 2014
- Russ Britt

The double-edged sword of growth-stock speculation
2:29 p.m. Nov. 14, 2014
- The Trading Deck

10 S&P 500 companies with the fastest revenue growth
8:28 a.m. Nov. 11, 2014
- Philip van Doorn

Merck, Dendreon miss out on health-care rally
12:39 p.m. Nov. 10, 2014
- Russ Britt

Gilead Sciences rises 2% to top S&P 500 gainers
9:31 a.m. Nov. 10, 2014
- Sue Chang

Visa shares rise after hours on earnings beat
6:50 p.m. Oct. 29, 2014
- Sue Chang

Warren Buffett best wear his trunks as Fed preps to end (pause) the printing
8:34 a.m. Oct. 29, 2014
- Shawn Langlois

Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang

Updates, advisories and surprises
5:01 p.m. Oct. 28, 2014
- MarketWatch

Sales of Gilead's pricey hepatitis C drug slow
4:26 p.m. Oct. 28, 2014
- MarketWatch.com

Gilead Sciences' stock pulls back from record high close after earnings miss
4:14 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead's stock drops 3.6% in after-hours trade after Q3 results
4:09 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln
4:08 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales top FactSet consensus estimate of $5.99 bln
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 net EPS $1.67 vs. 47 cents a year ago
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore

Two biotech leaders to watch
2:12 p.m. Oct. 28, 2014
- The Trading Deck

France gets larger discount on Sovaldi than its neighbors

45 min ago12:04 p.m. Nov. 20, 2014
- Seeking Alpha

Global drug tab will breach trillion dollar mark this year

7:41 a.m. Today7:41 a.m. Nov. 20, 2014
- Seeking Alpha

CNBC's Stock Pops & Drops From November 19

6:38 a.m. Today6:38 a.m. Nov. 20, 2014
- benzinga.com

Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog

5:57 p.m. Nov. 19, 2014
- Zacks.com

Why We're Huge Fans Of Gilead

4:33 p.m. Nov. 19, 2014
- Seeking Alpha

Gilead buys FDA voucher for $125M

3:59 p.m. Nov. 19, 2014
- Seeking Alpha

Gilead: Pipeline Now Includes Potential Renal Blockbuster

11:35 a.m. Nov. 19, 2014
- Seeking Alpha

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

11:23 a.m. Nov. 19, 2014
- Zacks.com

Update: Gilead's Harvoni Receives Marketing Authorization In Europe

11:17 a.m. Nov. 19, 2014
- Seeking Alpha

Stock Market News for November 19, 2014 - Market News

10:10 a.m. Nov. 19, 2014
- Zacks.com

Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High

4:09 p.m. Nov. 18, 2014
- TheStreet.com

Gilead's Value Without Its Hep C Franchise

4:07 p.m. Nov. 18, 2014
- Seeking Alpha

Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide

2:23 p.m. Nov. 18, 2014
- TheStreet.com

Stock Movers: Why 4 Big Drug Stocks Are Rising Today

1:38 p.m. Nov. 18, 2014
- Investors Business Daily

Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni

10:48 a.m. Nov. 18, 2014
- TheStreet.com

Buy Gilead Sciences Now At A Historic Low Valuation

8:52 a.m. Nov. 18, 2014
- Seeking Alpha

Dispelling Some Of The Myths Surrounding Gilead Sciences.

8:22 a.m. Nov. 18, 2014
- Seeking Alpha

Trade of the Day: Gilead Sciences (GILD)

3:16 a.m. Nov. 18, 2014
- InvestorPlace.com

Trade of the Day: Gilead Sciences Stock on Sale

7:56 p.m. Nov. 17, 2014
- InvestorPlace.com

Incyte Building Blockbuster Drug One Disease At A Time

2:58 p.m. Nov. 17, 2014
- Investors Business Daily

Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
8:45 a.m. Today8:45 a.m. Nov. 20, 2014
- PR Newswire - PRF

Knight Sells Priority Review Voucher to Gilead
5:11 p.m. Nov. 19, 2014
- Marketwired

European Commission Grants Marketing Authorization for Gilead’s
Harvoni®▼ (Ledipasvir/Sofosbuvir), the First
Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C
Patients With Genotype 1 and 4
10:07 a.m. Nov. 18, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
8:45 a.m. Nov. 18, 2014
- PR Newswire - PRF

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
9:10 a.m. Nov. 14, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
8:45 a.m. Nov. 14, 2014
- PR Newswire - PRF

Gilead Prices $4 Billion of Senior Unsecured Notes
5:59 p.m. Nov. 12, 2014
- BusinessWire - BZX

Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
8:45 a.m. Nov. 12, 2014
- PR Newswire - PRF

Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of
Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Gilead Announces Harvoni Study Results in Chronic Hepatitis C
Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
8:45 a.m. Nov. 10, 2014
- PR Newswire - PRF

Medifocus to Be Broadcast on BNN and Fox Business News on November
8th and 9th, 2014
10:56 a.m. Nov. 7, 2014
- Marketwired

Linkage Biosciences Adds to Board Leadership
8:02 a.m. Nov. 7, 2014
- Marketwired

Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver
9:31 a.m. Nov. 6, 2014
- PR Newswire - PRF

Gilead Submits New Drug Application to U.S. Food and Drug
Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet
Regimen for HIV
8:32 a.m. Nov. 6, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties
8:45 a.m. Nov. 4, 2014
- PR Newswire - PRF

Life-Science New Build Report: 200 New North American Sites in
Planning Represent Potential $15 Billion Investment, an Industrial
Info News Alert
6:16 a.m. Nov. 4, 2014
- Marketwired

Gilead Sciences Once Again Tops the List of California's Most Honored
Companies in Institutional Investor's All-America Executive Team
Ranking
6:15 a.m. Nov. 4, 2014
- Marketwired

Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro
8:45 a.m. Oct. 30, 2014
- PR Newswire - PRF

Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
8:35 a.m. Oct. 29, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

West Physics Expands Reach with Radiographic Testing Buy

A Strategic Move in Medical Physics When you're at the helm of a ship like West Physics, every strategic move you make sends ripples through the industry. Their recent acquisition of Radiographic Testing Services, Inc. (RTS) is exactly that—one colossal wave. No one who knows the ins and outs of imaging services can scoff at this maneuver. It's a well-calculated step...

Globant Unleashes MuleSoft AI Pod for Faster Integration

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

Lear Corporation Talks Future at Morgan Stanley Conference

Why the Chatter at Laguna Conference Matters Alright folks, here's the scoop that the suits over at Lear are gearing up for: a fireside chat at the Morgan Stanley 14th Annual Laguna Conference. At first glance, you might shrug and say, "Big deal." But what's a conference worth if not to attract a bit of investor buzz, right? With Ray Scott, the President and CEO, and...

Curve Memberships: A New Path for Dental Practices

Revolutionizing Dental Practice Management Ever met a dentist who says they love dealing with insurance bureaucracies? Yeah, me neither. Curve Dental's latest gambit into membership plans is aiming to slice right through that mess. They've launched a shiny new component aptly named Curve Memberships. This isn't just some fly-by-night addon; it's about deep...

Kentucky Set for Cannabis Expo on September 19th

Demystifying Cannabis in Bluegrass State Forget what you thought you knew about Kentucky—it's stepping onto the cannabis scene, one educational Expo at a time. Come September 19, the Central Bank Center in Lexington is playing host to the Kentucky Cannabis & Wellness Expo. Not just any expo, mind you—a free, all-access pass to all things cannabis-related where no...

UNISORB Expands Reach with BILZ Acquisition

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

AEC Firms Revamp Strategies Amid Talent Tug-of-War

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

HIMS Faces Class Action: Investors Eye Leadership

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Taiwan's Machine Emerges as Heavy-Tonnage Game Changer

Every once in a while, the machinery scene gets rocked by something that genuinely raises eyebrows, and it seems Chuan Lih Fa Machinery Works Co., Ltd. (CLF) has just delivered one of those moments. This isn't just any old injection molding machine—it's Taiwan's very first 5000-ton giant, crafted with robust precision and dispatched straight to a major U.S. logistics...

TETRA Technologies to Engage at Key Investor Events

Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....